Neuroprotective Potential of Eugenol in Polyglutamine-Mediated Neurodegenerative Disease Using Transgenic Model

• Հիմնական հեղինակներ: Anjalika Chongtham (Հեղինակ), Namita Agrawal (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: SAGE Publishing, 2024-10-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

Polyglutamine (PolyQ) diseases including Huntington's disease are devastating neurodegenerative disorders characterized by progressive neuronal loss and motor dysfunction. PolyQ pathology involves multiple cellular events and phytochemicals with multi-target mechanisms hold promise to treat the...